Citadel Advisors’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.09M Buy
171,700
+142,300
+484% +$2.73M ﹤0.01% 5088
2026
Q1
$518K Buy
+29,400
New +$590K ﹤0.01% 9215
2025
Q4
Sell
-49,200
Closed -$859K 12561
2025
Q3
$859K Buy
49,200
+19,600
+66% +$291K ﹤0.01% 7874
2025
Q2
$414K Sell
29,600
-27,600
-48% -$444K ﹤0.01% 9075
2025
Q1
$1.07M Sell
57,200
-7,400
-11% -$110K ﹤0.01% 6824
2024
Q4
$727K Buy
+64,600
New +$755K ﹤0.01% 7733
2024
Q3
Sell
-1,100
Closed -$8.6K 14159
2024
Q2
$8.6K Buy
1,100
+400
+57% +$2.61K ﹤0.01% 13178
2024
Q1
$3.47K Sell
700
-3,000
-81% -$19.2K ﹤0.01% 13899
2023
Q4
$31.9K Sell
3,700
-5,600
-60% -$41K ﹤0.01% 12216
2023
Q3
$64.5K Buy
+9,300
New +$56.1K ﹤0.01% 11434
2023
Q1
Sell
-11,200
Closed -$132K 14656
2022
Q4
$132K Buy
+11,200
New +$136K ﹤0.01% 10811
2021
Q3
Sell
-11,100
Closed -$259K 13739
2021
Q2
$259K Buy
+11,100
New +$270K ﹤0.01% 11619

Other funds holding ALHC

Citadel Advisors's ALHC Position: Q2 2026 in Review

Citadel Advisors sold out of Alignment Healthcare (ALHC) in Q2 2026, closing a stake of 5,362,666 shares — an estimated $103M sold.

Citadel Advisors first reported a position in ALHC in Q2 2021 and held it in 18 quarters. The position peaked at $117M in Q2 2025. 324 funds tracked by Wall St. Rank hold ALHC as of Q2 2026.

  • Citadel Advisors reported no remaining Alignment Healthcare position as of Q2 2026 after selling out during the quarter.
  • Citadel Advisors sold 5,362,666 Alignment Healthcare shares in Q2 2026, an estimated $103M.
  • Citadel Advisors first reported a position in Alignment Healthcare in Q2 2021 and held it in 18 quarters.
  • Citadel Advisors's Alignment Healthcare position peaked at $117M in Q2 2025.
  • 324 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.